Sunshine Biopharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Sunshine Biopharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 454% to $24,092,787. The net income raised on -$4,506,044 and profit margin reached -19%. Total operating expenses were $13,124,470.
Profit Margin
| 2014 | 0 | -1.93M | |
|---|---|---|---|
| 2015 | 1.70K | -1.65M | -96774.47% |
| 2016 | 0 | -3.49M | |
| 2017 | 0 | -1.04M | |
| 2018 | 447.2K | -2.15M | -482.15% |
| 2019 | 21.12K | -1.46M | -6919.37% |
| 2020 | 71.41K | -897.68K | -1257.08% |
| 2021 | 228.42K | -12.76M | -5588.36% |
| 2022 | 4.34M | -26.74M | -615.44% |
| 2023 | 24.09M | -4.50M | -18.7% |
SBFMW Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 24.09M | 4.34M | 228.42K | 71.41K | 21.12K | 447.2K | 0 | 0 | 1.70K | 0 |
Cost of revenue | 15.75M | 2.64M | 117.83K | 25.84K | 11.05K | 391.08K | 6.62K | 0 | 384.58K | 263.33K |
Gross profit | 8.33M | 1.69M | 110.59K | 45.56K | 10.07K | 56.11K | -6.62K | 0 | -382.87K | -263.33K |
Operating exp. | ||||||||||
Research and development | 1.85M | 811.85K | 672.20K | 60.94K | 15.20K | 12.8K | 0 | 32.79K | 8.65K | 327K |
Selling and marketing | 734.24K | 578.08K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 105K |
Total operating expenses | 13.12M | 10.37M | 2.55M | 622.43K | 651.70K | 1.22M | 857.19K | 993.10K | 781.98K | 1.75M |
Operating income | -4.78M | -8.67M | -2.44M | -576.87K | -641.63K | -1.16M | -857.19K | -993.10K | -780.27K | -1.75M |
Other income (expenses), net | 674.42K | -17.83M | -9.99M | -2.20M | -436.41K | -830.19K | -183.04K | -2.46M | -872.63K | -179.09K |
Income before tax | -4.11M | -26.51M | -12.43M | -2.78M | -1.07M | -2.15M | -1.04M | -3.49M | -1.65M | -1.93M |
Income tax expense | 395.16K | 233.30K | 328.81K | -1.88M | 383.38K | -41.52K | 1.28K | 2.46M | 565.42K | -1.74M |
Net income | -4.50M | -26.74M | -12.76M | -897.68K | -1.46M | -2.15M | -1.04M | -3.49M | -1.65M | -1.93M |
Earnings per share | ||||||||||
Basic EPS | -370.41 | -176.17 | -81.45 | -1.03K | -6.68 | -35.38 | -23.84 | -658.51 | -270.44 | -526.17 |
Diluted EPS | -370.41 | -176.17 | -81.45 | -1.03K | -6.68 | -35.38 | -23.84 | -658.51 | -270.44 | -526.17 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |